Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Pierson

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Human Molecular Genetics|January 12, 2013
Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathyMichael W Lawlor, Dustin Armstrong, Marissa G Viola, et al.
Journal of Neuro-Oncology|January 31, 2014
Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomasKathleen Dorris, Matthew Sobo, Arzu Onar-Thomas, et al.
Diagnostic Pathology|January 22, 2026
Clinical and molecular characteristics of constitutional mismatch repair deficiency syndrome: a case series of five children and appraisal of diagnostic guidelinesJennifer Vazzano Goldstone, Suzanna J Logan, Benjamin J Wilkins, et al.
Human Molecular Genetics|April 25, 2008
AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasisAnna Buj-Bello, Françoise Fougerousse, Yannick Schwab, et al.
Neuro-Oncology|November 26, 2019
ΔNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastomaMaren Cam, Manish Charan, Alessandra M Welker, et al.
Disease Models & Mechanisms|May 31, 2012
Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse modelsJames J Dowling, Romain Joubert, Sean E Low, et al.
Pediatric Blood & Cancer|December 2, 2017
Long-term evidence that a pediatric oncology mentorship program for young investigators is feasible and beneficial in the cooperative group setting: A report from the Children's Oncology GroupAdam J Esbenshade, Christopher R Pierson, Amanda L Thompson, et al.
Human Molecular Genetics|November 10, 2011
Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotypeChristopher R Pierson, Ashley N Dulin-Smith, Ashley N Durban, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 23, 2023
Novel MECP2 gene therapy is effective in a multicenter study using two mouse models of Rett syndrome and is safe in non-human primatesSamantha Powers, Shibi Likhite, Kamal K Gadalla, et al.
Acta Neuropathologica Communications|November 21, 2022
Molecular and spatial heterogeneity of microglia in Rasmussen encephalitisJesse J Westfall, Wesley N Schwind, Sahibjot Sran, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Human Molecular Genetics|January 12, 2013
Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathyMichael W Lawlor, Dustin Armstrong, Marissa G Viola, et al.
Journal of Neuro-Oncology|January 31, 2014
Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomasKathleen Dorris, Matthew Sobo, Arzu Onar-Thomas, et al.
Diagnostic Pathology|January 22, 2026
Clinical and molecular characteristics of constitutional mismatch repair deficiency syndrome: a case series of five children and appraisal of diagnostic guidelinesJennifer Vazzano Goldstone, Suzanna J Logan, Benjamin J Wilkins, et al.
Human Molecular Genetics|April 25, 2008
AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasisAnna Buj-Bello, Françoise Fougerousse, Yannick Schwab, et al.
Neuro-Oncology|November 26, 2019
ΔNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastomaMaren Cam, Manish Charan, Alessandra M Welker, et al.
Disease Models & Mechanisms|May 31, 2012
Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse modelsJames J Dowling, Romain Joubert, Sean E Low, et al.
Pediatric Blood & Cancer|December 2, 2017
Long-term evidence that a pediatric oncology mentorship program for young investigators is feasible and beneficial in the cooperative group setting: A report from the Children's Oncology GroupAdam J Esbenshade, Christopher R Pierson, Amanda L Thompson, et al.
Human Molecular Genetics|November 10, 2011
Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotypeChristopher R Pierson, Ashley N Dulin-Smith, Ashley N Durban, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 23, 2023
Novel MECP2 gene therapy is effective in a multicenter study using two mouse models of Rett syndrome and is safe in non-human primatesSamantha Powers, Shibi Likhite, Kamal K Gadalla, et al.
Acta Neuropathologica Communications|November 21, 2022
Molecular and spatial heterogeneity of microglia in Rasmussen encephalitisJesse J Westfall, Wesley N Schwind, Sahibjot Sran, et al.
Pageof 11